Pharmaceutical

shutterstock_1074052646 (1)

That’s ODD: can your medicine benefit from incentives for treating rare disorders?

The time, resources, and costs of developing and marketing medicines are extensive – putting treatments for rare disorders at a distinct disadvantage since the potential return on investment is limited...
shutterstock_181476422 (1)

Addendum to TGA Deadlines: Medicine Labelling Compliance and COVID-19

As described in the Upcoming TGA Deadlines for Medicine Labelling and Product Information Reform article the transition period for Australian Medicines Packaging Reform concludes on 31 August 2020. As a...
Medicine packaging

Upcoming TGA Deadlines for Medicine Labelling and Product Information Reform

2020 was flagged to be a big year for TGA Sponsors of Medicines with two long-standing milestones on the horizon. Whilst there is no doubt this won’t be a year...

Search

Recent Posts

Categories

Categories

Archives

Archives

Archives